Clinical Trial Details

Trial ID: L0797
Source ID: IRCT20121105011375N5
Associated Drug: Silymarin
Title: Effect of silymarin, metformin, and life style in patients with non-alcoholic fatty liver disease in Marvdasht Hospital
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic fatty liver. <br>Nonalcoholic steatohepatitis (NASH);K75.81
Interventions: Intervention 1: Intervention group: lifestyle modification and Metformin 500 mg/day for 3 months. Intervention 2: Intervention group: lifestyle modification and Silymarin 140 mg/day for 3 months. Intervention 3: Control group: lifestyle modification and p
Outcome Measures: Liver function test. Timepoint: Before intervention, 3 months after intervention. Method of measurement: ELISA.Body Mass Index. Timepoint: Before intervention, 3 months after intervention. Method of measurement: By BMI Formula.
Sponsor/Collaborators: Shiraz University of Medical Sciences
Gender: All
Age: 18 years60 years
Phases: Not applicable
Enrollment: 90
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done using a randomization table based on the registration number of the patients. Study pills w
Start Date: 10/05/2018
Completion Date: --
Results First Posted: --
Last Update Posted: 18 June 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/30794